|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 美国腹腔镜内镜手术协会有关单孔腹腔镜手术的共识显示文摘 | Gill IS Advincula AP Aron M 谢晓峰 朱江帆 | 2010 | 中国微创外科杂志2010，10，11： | 51 |
| 2 | Correlation of E-selectin gene polymorphisms with risk of ischemic stroke A meta-analysis显示文摘OBJECTIVE: To investigate the association of E-selectin S128R polymorphisms with ischemic stroke. DATA SOURCES: A computer-based online search was conducted in PubMed, Elsevier, Ovid Database, the China National Knowledge Infrastructure, and Wanfang Database between January 1998 and December 2010. STUDY SELECTION: Case-controlled studies addressing the association of the E-selectin polymorphism and ischemic stroke were included in this review. The genotype distribution complied with the Hardy-Weinberg genetic equilibrium. The included reports were evaluated by two authors for strict quality screening. Meta-analysis software, REVMAN 5.1, was used to investigate heterogeneity, pooled odds ratio (OR) and 95% confidence interval (CI) in individual studies. MAIN OUTCOME MEASURES: Genotype and allele distributions at the E-selectin S128R site. RESULTS: Six case-controlled studies were included after screening and application of inclusion and exclusion criteria. There was no heterogeneity in the genotype and allele frequencies, and no publication bias was found. Meta-analysis of the pooled data showed that the OR value of the (AC+CC)/AA genotype was 1.93 (95% CI: 1.55-2.41, Z = 5.80, P < 0.000 01), and the OR for the C/A allele was 1.80 (95% CI: 1.47-2.22, Z = 5.59, P < 0.000 01) in the ischemic stroke group, compared with control group. Results of pooled data in Chinese subjects showed that the OR value of (AC+CC)/AA was 2.36 (95% CI: 1.68-3.31, Z = 4.99, P < 0.000 01), and the OR value of the C/A allele was 2.25 (95% CI: 1.63-3.12, Z = 4.89, P < 0.000 01). CONCLUSION: Polymorphism of E-selectin S128R was significantly associated with susceptibility to ischemic stroke; the AC and CC genotypes as well as the C allele may be factors associated with susceptibility to ischemic stroke. | Qingli Sun Yu Fu Aping Sun Yanhong Shou Mei Zheng Xiaogang Li Dongsheng Fan | 2011 | Neural Regeneration Research2011，6，22： | 46 |
| 3 | 联合应用伏立康唑和卡泊芬净可有效治疗侵袭性曲霉感染显示文摘背景:联合应用伏立康唑和卡泊芬净作为器官移植患者侵袭性曲霉感染的基础性治疗方法的疗效尚未进行研究。 | Singh N Limaye AP Forrest G 邓妍 | 2006 | 中国处方药2006，5，3： | 28 |
| 4 | 北京居民对2008奥运会影响的态度和看法显示文摘通过对1165名北京居民的电话调查分析其对2008奥运会影响的态度和看法,本文验证发展出4个方面的(社会心理、社会生活、城市发展、经济发展)20条具体盛事影响的条目。另外,依照对奥运影响的看法,居民被分为两个组群:积极派和中间派。一些影响居民组群归属的固定变量得以确认。调查结果建议在奥运规划准备过程中更多了解当地居民的意见将有助于取得奥运会的全面成功。 | 周勇 John Ap | 2008 | 旅游学刊2008，23，7： | 27 |
| 5 | 多粘菌素B治疗耐多药病原菌研究进展显示文摘由于耐多药革兰阴性菌院内感染在全世界广泛流行,目前尚无新的针对性抗菌药物被研发,所以多粘菌素B又被应用于临床。目前多粘菌素B和粘菌素为这些感染治疗的最后选择。本文综述了多粘菌素B的微生物学、药代动力学、药效学和临床学资料。多粘菌素B在体外,对常见耐多药革兰阴性菌,如铜绿假单胞菌、鲍氏不动杆菌、肺炎克雷伯菌,有迅速杀灭作用。对其耐药的病原菌还很少见。近期研究显示,多粘菌素B静脉治疗后大部分患者疗效好。但这些研究由于存在设计缺陷,需要进行更多的临床研究。尽管体外试验结果提示联合治疗是不错选择,但没有临床的研究给予支持。鉴于多粘菌素类将越来越多地用于治疗耐多药病原菌感染,迫切需要进一步进行临床药代动力学、药效学和毒理学的研究,来指导该药的使用。 | Zavascki AP Goldanilz LJ 周颖杰 施耀国 | 2008 | 国际药学研究杂志2008，35，4： | 21 |
| 6 | Strategies to reduce pulmonary complications after esophagectomy显示文摘Esophagectomy,the surgical removal of all or part of the esophagus,is a surgical procedure that is associated with high morbidity and mortality.Pulmonary complications are an especially important postoperative problem.Therefore,many perioperative strategies to prevent pulmonary complications after esophagectomy have been investigated and introduced in daily clinical practice.Here,we review these strategies,including improvement of patient performance and technical advances such as minimally invasive surgery that have been implemented in recent years.Furthermore,interventions such as methylprednisolone,neutrophil elastase inhibitor and epidural analgesia,which have been shown to reduce pulmonary complications,are discussed.Benefits of the commonly applied routine nasogastric decompression,delay of oral intake and prophylactic mechanical ventilation are unclear,and many of these strategies are also evaluated here.Finally,we will discuss recent insights and new developments aimed to improve pulmonary outcomes after esophagectomy. | Teus J Weijs Jelle P Ruurda Grard AP Nieuwenhuijzen Richard van Hillegersberg Misha DP Luyer | 2013 | World Journal of Gastroenterology2013，19，39： | 17 |
| 7 | 舌癌CN0患者选择性颈淋巴清扫和颈部观察的前瞻性随机研究显示文摘Prospective randomized study of selective neck dissection versus observation for NO neck of early tongue carcinoma. Yuen AP, Ho CM, Chow TL, et al. Head Neck, 2009, 31(6):765-772. | Yuen AP Ho CM Chow TL | 2009 | 中国口腔颌面外科杂志2009，7，4： | 16 |
| 8 | 膝关节粘连:治疗和预防研究新进展显示文摘背景:膝关节粘连严重影响了患者术后的日常生活,而传统的治疗方式疗效有限。降低膝关节粘连发生率是提高手术预期疗效的关键,也是临床医学上需要急待解决的重要问题。目的:对膝关节粘连的各类研究文献进行分析,总结近10年的研究成果,为防治膝关节粘连提供新的思路和方法。方法:由第一作者检索Pub Med数据库,查找2006至2016年的文献,英文检索词为'tissue adhesions,arthrofibrosis,joint stiffness,prevent,treatment',共检索到1 500余篇相关文献,59篇符合纳入标准。结果与结论:(1)近年来大量学者研究发现,创伤/手术引起膝关节出血、炎症反应,造成血管内皮细胞生长因子和白细胞介素6高表达,增加了成纤维细胞的活性,导致大量胶原蛋白沉积,发生粘连;(2)改进传统治疗方式和运用微创技术治疗膝关节粘连取得了一定的疗效,但仍存在再粘连风险;(3)关节腔内用药预防膝关节粘连在基础研究方面获得了显著成果,可成为预防膝关节粘连的一种有效方案,但临床可行性存在争议,需进一步深入研究,寻找疗效确切、不良反应小的药物。 | 吴海啸 王鹏 张超 Egiazaryan KA Ratyev AP Melnichenko SY Kuzin VV Skoroglyadov AV | 2017 | 中国组织工程研究2017，21，36： | 12 |
| 9 | 宣肺健脾益肾针刺法对支气管哮喘患者肺功能与心率变异性即刻效应的影响显示文摘目的 :探讨针刺治疗支气管哮喘 (简称哮喘 )的作用机理。方法 :慢性持续期、缓解期哮喘患者 ,针刺治疗主要穴位有 :列缺、鱼际、曲池、足三里、三阴交、太溪等 ,体现了中医宣肺健脾益肾的治疗原则。针刺治疗前后 15min检测肺功能与心率变异性 (HRV)频域指标。结果 :针刺治疗后哮喘患者的肺功能出现明显改善 ,HRV测定表明机体植物神经的调节功能得到加强。结论 :针刺治疗对提高哮喘患者的肺功能具有显著即刻效应 。 | 张文彭 Е.В.ВЛАGNМNPCKNN N В.Л.КYЧEPCK N N E.B.CEMEN H ЫX E.Г.ПAPШAKOBA | 2004 | 中国中医基础医学杂志2004，10，9： | 12 |
| 10 | Mechanisms of angiogenesis in gliomas显示文摘 | Kargiotis O Rao JS Kyritsis AP | 2006 | 中国神经肿瘤杂志2006，4，1： | 12 |
| 11 | Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer显示文摘Early screening for colorectal cancer(CRC) holds the key to combat and control the increasing global burden of CRC morbidity and mortality. However, the current available screening modalities are severely inadequate because of their high cost and cumbersome preparatory procedures that ultimately lead to a low participation rate. People simply do not like to have colonoscopies. It would be ideal, therefore, to develop an alternative modality based on blood biomarkers as the first line screening test. This will allow for the differentiation of the general population from high risk individuals. Colonoscopy would then become the secondary test, to further screen the high risk segment of the population. This will encourage participation and therefore help to reach the goal of early detection and thereby reduce the anticipated increasing global CRC incidence rate. A blood-based screening test is anappealing alternative as it is non-invasive and poses minimal risk to patients. It is easy to perform, can be repeated at shorter intervals, and therefore would likely lead to a much higher participation rate. This review surveys various blood-based test strategies currently under investigation, discusses the potency of what is available, and assesses how new technology may contribute to future test design. | Ganepola AP Ganepola Joel Nizin John R Rutledge David H Chang | 2014 | World Journal of Gastrointestinal Oncology2014，6，4： | 11 |
| 12 | Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer显示文摘AIM:To develop a panel of blood-based diagnostic biomarkers consisting of circulating microRNAs for the detection of pancreatic cancer at an early stage.METHODS:Blood-based circulating microRNAs were profiled by high throughput screening using microarray analysis,comparing differential expression between early stage pancreatic cancer patients(n = 8) and healthy controls(n = 11).A panel of candidate microRNAs was generated based on the microarray signature profiling,including unsupervised clustering and statistical analysis of differential expression levels,and findings from the published literature.The selected candidate microRNAs were then confirmed using TaqMan real-time quantitative reverse transcription polymerase chain reaction(RT-qPCR) to further narrow down to a three-microRNA diagnostic panel.The three-microRNA diagnostic panel was validated with independent experimental proce-dures and instrumentation of RT-qPCR at an independent venue with a new cohort of cancer patients(n = 11),healthy controls(n = 11),and a group of high risk controls(n = 11).Receiver operating characteristic curve analysis was performed to assess the diagnostic capability of the three-microRNA panel.RESULTS:In the initial high throughput screening,1220 known human microRNAs were screened for differential expression in pancreatic cancer patients versus controls.A subset of 42 microRNAs was then generated based on this data analysis and current published literature.Eight microRNAs were selected from the list of 42 targets for confirmation study,and three-microRNAs,miR-642b,miR-885-5p,and miR-22,were confirmed to show consistent expression between microarray and RT-qPCR.These three microRNAs were then validated and evaluated as a diagnostic panel with a new cohort of patients and controls and found to yield high sensitivity(91%) and specificity(91%) with an area under the curve of 0.97(P < 0.001).Compared to the CA19-9 marker at 73%,the three-microRNA panel has higher sensitivity although CA19-9 has higher specificity of 100%.CONCLUSION:The identified panel of three microRNA biomarkers can potentially be used as a diagnostic tool for early stage pancreatic cancer. | Ganepola AP Ganepola John R Rutledge Paritosh Suman Anusak Yiengpruksawan David H Chang | 2014 | World Journal of Gastrointestinal Oncology2014，6，1： | 9 |
| 13 | 异型缝隙连接通道和磷酸化对心脏缝隙连接的调变显示文摘目的 检测由缝隙连接蛋白 (connexin ,Cx) 4 3和Cx4 5组成的多种异型缝隙连接通道 (het eromultimericgapjunctionchannels ,HGJC)和磷酸化对缝隙连接 (gapjunction ,GJ)的调变作用。方法 将转染了编码为Cx4 3或Cx4 5的DNA后的Hela细胞放置在一起共同培养组成双侧和单侧异型GJ通道。显微注射若丹明 12 3(rhodamine 12 3,Rh)检测经 2 0 0nmol/L十四 (烷 )酰佛波醇乙酸酯 (12 0 tetrade canoylphorbol 13 acetae ,TPA)处理前后 ,在紫外光显示下由Cx4 3和Cx4 5所组成的不同GJ通道对荧光染料的偶联率 (couplingratio)。结果 在不同的GJ中 ,同型GJ通道Cx4 3(homotypicCx4 3,HoCx4 3)偶联率最高。从Cx4 5侧注入荧光染料的单侧异型GJ通道 4 5 (mono heteromericCx4 5 Cx4 3/4 5 ,MH4 5 )偶联率较之从Cx4 3/4 5侧注入荧光染料的MH4 5、双侧异型GJ通道Cx4 3/4 5 (bi heteromericCx4 3/4 5 ,BH4 3/4 5 )及同型GJ通道Cx4 5 (homotypicCx4 5 ,HoCx4 5 )等的偶联率是最低的。根据HoCx4 3或HoCx4 5通道的偶联率对各型通道偶联率进行标准化处理。BH4 3/4 5和MH4 3通道的偶联率均较HoCx4 3降低。对MH4 5通道来说 ,从Cx4 3/4 5侧注射的通道偶联率大于从Cx4 5侧注射的偶联率。TPA处理后HoCx4 3的偶联率降低 。 | 钟国强 黄从新 刘唐威 Mantel PL Moreno AP | 2003 | 中华心律失常学杂志2003，7，4： | 9 |
| 14 | RTOG 0211:a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients显示文摘PURPOSE: To determine the safety and efficacy of gefitinib,an epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor,in combination with radiation for newly diagnosed glioblastoma(GBM) patients.METHODS AND MATERIALS: Between March 21,2002,and May 3,2004,Radiation Therapy Oncology Group(RTOG) 0211 enrolled 31 and 147GBM patients in the phase 1 and 2 arms,respectively.Treatment consisted of daily oral gefinitnib started at the time of conventional cranial radiation therapy(RT) and continued post RT for 18 months or until progression.Tissue microarrays from 68 cases were analyzed for EGFR expression.RESULTS: The maximum tolerated dose(MTD) of gefitinib was determined to be 500 mg in patients on non-enzyme-inducing anticonvulsant drugs(non-EIAEDs).All patients in the phase 2 component were treated at a gefitinib dose of 500 mg;patients receiving EIADSs could be escalated to 750 mg.The most common side effects of gefitinib in combination with radiation were dermatologic and gastrointestinal.Median survival was 11.5 months for patients treated per protocol.There was no overall survival benefit for patients treated with gefitinib + RT when compared with a historical cohort of patients treated with RT alone,matched by RTOG recursive partitioning analysis(RPA) class distribution.Younger age was significantly associated with better outcome.Per protocol stratification,EGFR expression was not found to be of prognostic value for gefitinib + RT-treated patients.CONCLUSIONS: The addition of gefitinib to RT is well tolerated.Median survival of RTOG 0211 patients treated with RT with concurrent and adjuvant gefitinib was similar to that in a historical control cohort treated with radiation alone. | Chakravarti A Wang M Robins HI Lautenschlaeger T Curran WJ Brachman DG Schultz CJ Choucair A Dolled-Filhart M Christiansen J Gustavson M Molinaro A Mischel P Dicker AP Bredel M Mehta M | 2013 | 中国神经肿瘤杂志2013，11，1： | 8 |
| 15 | 固定低剂量三联抗高血压药物与常规治疗对斯里兰卡轻度至中度高血压患者血压控制的疗效差异:一项随机临床试验显示文摘控制不良的高血压是全球领先的公共卫生问题,需要新的治疗策略。该研究评估低剂量三联抗高血压药物治疗是否能达到比常规治疗更好的血压控制。研究者纳入2016年2月至2017年5月在斯里兰卡11所城市医院诊所就诊的需要开始抗高血压治疗(未治疗的患者)或接受单药治疗的患者,进行低剂量三联降压与常规治疗比较的随机、开放性试验,随访至2017年10月。 | Web-ster R Salam A de Silva HA Selak V Stepien S Rajapakse S Amarasekara S Amarasena N Billot L de Silva AP Fernando M Guggilla R Jan S Jayawardena J Maulik PK Mendis S Munasinghe J Naik N Prabhakaran D Ranasinghe G Thom S Tisserra N Senaratne V Wijekoon S Wijeyasingam S Rodgers A Patel A 刘莉 叶鹏 | 2018 | 中华高血压杂志2018，26，12： | 7 |
| 16 | Slower cycling of nestin-positive cells in neurosphere culture显示文摘 | Ma BF Liu XM Xie XM Zhang AX Zhang JQ Yu WH Zhang XM Li SN Lahn BT Xiang AP | 2006 | 中国生物学文摘2006，20，5： | 4 |
| 17 | The Virulence Plasmid of Yersinia, an Antihost Genome 显示文摘 | Cornelis GR Boland A Boyd AP | 1998 | Microbiology and Molecular Biology Reviews1998，62，： | 4 |
| 18 | 大量输血的并发症及输血反应显示文摘围手术期输血问题是极端复杂的问题。对于应何时输血的新观点是针对病毒传播及输血的免疫效应两方面而产生的。为保护患者免于不必要输血的危险,应考虑患者的整体情况连同外科手术方式以及进一步失血可能性的大小,以便有助于指导决定若要输,输什么血液制品。过去那种“血细胞比容低于30%就应该输血”的所谓格言现已不再被人接受了。特别重要的问题是需要大量输血(估计为患者血容量的1.5倍以上)的病人,输入如此大量的血可以预计有一系列围手术期的凝血障碍、代谢性和免疫方面的并发症。 | Marco AP Furman WR 陈鲳 | 1993 | 国外医学(输血及血液学分册)1993，16，5： | 3 |
| 19 | Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death显示文摘 | Farb A Burke AP Tang AL | 1996 | Circulation1996，93，： | 3 |
| 20 | Propylthiouracyl-induced severe liver toxicity:An indication for alanine aminotransferase monitoring?显示文摘Propylthiouracyl (PTU)-related liver toxicity is likely to oc- cur in about 1% of treated patients. In case of acute or subacute hepatitis, liver failure may occur in about one third. We report two further cases of PTU-induced sub- acute hepatitis, in whom the delay between occurrence of liver damage after the initiation of treatment, the un- derestimation of its severity and the delayed withdrawal of the drug were all likely responsible for liver failure. The high incidence of liver toxicity related to PTU, its potential severity and delayed occurrence after initiation of treatment are in favor of monthly alanine aminotrans- ferase monitoring, at least during the first six months of therapy. | M Benyounes C Sempoux C Daumerie J Rahier AP Geubel | 2006 | World Journal of Gastroenterology2006，12，38： | 3 |
您所在的机构暂未开通此部分的功能，请联系管理员